[S,S]-Reboxetine
Sponsors
Pfizer
Conditions
Diabetic NeuropathiesFibromyalgiaHealthyPain
Phase 2
Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures
CompletedNCT00143442
Start: 2003-12-31End: 2004-10-31Target: 184Updated: 2006-08-08
[S,S]-Reboxetine Dose-Range Finding Trial
CompletedNCT00288652
Start: 2006-03-31End: 2007-02-28Target: 280Updated: 2011-06-08
[S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy.
TerminatedNCT00348894
Start: 2006-07-31End: 2007-10-31Updated: 2011-06-01
A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain.
TerminatedNCT00353808
Start: 2006-07-31End: 2007-10-31Updated: 2011-04-07
[S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.
TerminatedNCT00354094
Start: 2006-11-30End: 2007-10-31Target: 600Updated: 2007-11-08
A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia
CompletedNCT00357825
Start: 2006-08-31End: 2007-03-31Target: 246Updated: 2013-05-15
A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.
TerminatedNCT00625833
Start: 2007-12-31End: 2008-11-30Updated: 2019-12-13
Phase 3
Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia
TerminatedNCT00607256
Start: 2007-10-20End: 2009-05-18Updated: 2019-12-13
A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.
CompletedNCT00612170
Start: 2007-12-31End: 2009-05-31Updated: 2019-12-12
Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia
TerminatedNCT00754221
Start: 2008-05-31End: 2009-05-31Updated: 2019-12-17